Pharmaceutical

Elevating Patient Care: Senderra Specialty Pharmacy Adds EBGLYSS™ (lebrikizumab-lbkz), Lilly’s First-Line Biologic Treatment for Moderate-to-Severe Atopic Dermatitis, to SenderraCare+ for a Streamlined, Empowering Digital Patient Experience

Ultrack Systems Inc. (OTC: MJLB) Adds PUR Botanicals as Strategic Partner in PUR Rx Joint Venture: A Fully Vertically Integrated Natural Health Pharmacy Targeting Explosive Growth

TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB), a Canadian-based leader in wellness-focused technology and compliance-driven...

Junshi Biosciences Announces the Acceptance of the sNDA for Toripalimab as the 1st-line Treatment of HER2-expressing Urothelial Carcinoma

SHANGHAI, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading...

SoftWriters Announces the Official Availability of a New Cloud-Based Business Insights and Analytics Platform, FrameworkInsight

Introducing FrameworkInsight: An Innovative Cloud-Based Business Intelligence Platform for Long-Term Care (LTC) Pharmacies PITTSBURGH, PA / ACCESS Newswire / August...

AI-Powered Transformation Provides Immediate ROI and Drives Hospital C-Suite Innovation With 8 Key Benefits, Black Book Survey Reports

Advanced AI Solutions Provide Measurable Short-Term ROI, Strategic Decision-Making Benefits and Operational Improvements; New Survey Highlights Leading AI Healthcare Vendors...

error: Content is protected !!